1. Home
  2. IBRX vs ARE Comparison

IBRX vs ARE Comparison

Compare IBRX & ARE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

N/A

Current Price

$6.09

Market Cap

8.2B

Sector

Health Care

ML Signal

N/A

Logo Alexandria Real Estate Equities Inc.

ARE

Alexandria Real Estate Equities Inc.

N/A

Current Price

$40.52

Market Cap

7.4B

Sector

Real Estate

ML Signal

N/A

Company Overview

Basic Information
Metric
IBRX
ARE
Founded
2014
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Real Estate Investment Trusts
Sector
Health Care
Real Estate
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
7.4B
IPO Year
2015
1997

Fundamental Metrics

Financial Performance
Metric
IBRX
ARE
Price
$6.09
$40.52
Analyst Decision
Strong Buy
Hold
Analyst Count
4
16
Target Price
$14.25
★ $48.50
AVG Volume (30 Days)
★ 12.0M
2.2M
Earning Date
11-09-2026
10-26-2026
Dividend Yield
N/A
★ 6.89%
EPS Growth
★ 38.71
N/A
EPS
★ N/A
N/A
Revenue
$113,288,000.00
★ $3,026,556,000.00
Revenue This Year
$99.98
N/A
Revenue Next Year
$108.29
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
★ 668.31
N/A
52 Week Low
$1.95
$38.34
52 Week High
$12.43
$59.76

Technical Indicators

Market Signals
Indicator
IBRX
ARE
Relative Strength Index (RSI) 36.40 36.23
Support Level N/A $39.23
Resistance Level $8.62 $55.20
Average True Range (ATR) 0.57 1.61
MACD -0.10 -0.16
Stochastic Oscillator 10.19 0.00

Price Performance

Historical Comparison
IBRX
ARE

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

About ARE Alexandria Real Estate Equities Inc.

Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle, Texas, and Canada. The Company is a life science real estate investment trust focused on developing, redeveloping, and operating properties that provide space for lease to tenants in the life science industry.

Share on Social Networks: